Scientific Review of Thiotepa
Status: Listed in the Report on Carcinogens (RoC)
Primary Uses or Exposures: Thiotepa is used as a cytostatic agent in the treatment of lymphomas and a variety of solid and soft-tissue tumors.
No Public Comments
- NTP Board of Scientific Counselors RoC Subcommittee Meeting (November 18–19, 1996)
Note on Accessibility: Persons with disabilities or using assistive technology may find some documents are not fully accessible. For assistance, email us or use our contact form and identify the documents/pages for which access is required. We will assist you in accessing the content of these files. NIEHS has helpful information on accessibility.